Katie E Blise

9PUBLICATIONS
73CO-AUTHORS
Tumour immunologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 24, 2026
IFNγ-dependent tumor-cell MHC-II is restrained by MAPK signaling and associated with immunotherapy responsiveness in pancreatic ductal adenocarcinoma.

|Sep 04, 2026
The post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinoma.

|May 21, 2026
Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies.

|Dec 25, 2025
A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK pathway.

Motoyuki Tsuda, Dove Keith, Colin J Daniel

|Aug 12, 2025
Myc and Kras cooperate in adult acinar cells to drive phenotypic heterogeneity, metastasis, and therapeutic resistance in a novel pancreatic cancer mouse model.

Isabel A English, Patrick J Worth, Kevin Alexander MacPherson-Hawthorne

|Apr 28, 2025
Post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinoma.

Yifei Guo, Jennifer M Finan, Alexandra Q Bartlett

Pageof 2

Frequent Collaborators

7 joint publications

Shamilene Sivagnanam

7 joint publications

Lisa M Coussens

6 joint publications

Rosalie C Sears

4 joint publications

Jonathan R Brody